2 hours Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives Consensus Rating of “Buy” from Analysts MarketBeat
Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have received an average recommendation of “Buy” from the eleven analysts that are presently covering the firm, MarketBeat reports. Ten equities research analysts have rated the stock…